Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A melanoma (disease) that involves the mucosa.
Biomarker and diagnostic research for malignant melanoma of the mucosa has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for malignant melanoma of the mucosa.
154 publications have been identified in PubMed for malignant melanoma of the mucosa. Research spans Case Report / Case Series (28%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 43 | 28% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
29 |
19% |
Laboratory research | 28 | 18% |
Clinical study results | 17 | 11% |
Testing and diagnosis research | 15 | 10% |
Disease patterns and progression | 14 | 9% |
New treatment approaches | 7 | 5% |
Other research | 1 | 1% |
Monappa V (2026). [PMID: 41802132](https://pubmed.ncbi.nlm.nih.gov/41802132/). *Melanoma Res*. [Case Report / Case Series]
Kawahara M (2026). [PMID: 41846633](https://pubmed.ncbi.nlm.nih.gov/41846633/). *Cureus*. [Case Report / Case Series]
Young A (2026). [PMID: 33232096](https://pubmed.ncbi.nlm.nih.gov/33232096/). *Unknown Journal*. [Epidemiology / Natural History]
Bakhuis CFJ (2026). [PMID: 42025485](https://pubmed.ncbi.nlm.nih.gov/42025485/). *Int J Oral Maxillofac Surg*. [Review / Meta-Analysis]
Xu H (2026). [PMID: 41568455](https://pubmed.ncbi.nlm.nih.gov/41568455/). *Adv Anat Pathol*. [Review / Meta-Analysis]
Sebastian S (2026). [PMID: 41024740](https://pubmed.ncbi.nlm.nih.gov/41024740/). *Oral Dis*. [Review / Meta-Analysis]
Zhang Y (2026). [PMID: 41944928](https://pubmed.ncbi.nlm.nih.gov/41944928/). *Curr Treat Options Oncol*. [Review / Meta-Analysis]
Griffin Z (2026). [PMID: 39757680](https://pubmed.ncbi.nlm.nih.gov/39757680/). *Curr Pharm Des*. [Review / Meta-Analysis]
Liu S (2026). [PMID: 42106705](https://pubmed.ncbi.nlm.nih.gov/42106705/). *BMC Oral Health*. [Case Report / Case Series]
Mattei J (2026). [PMID: 41337670](https://pubmed.ncbi.nlm.nih.gov/41337670/). *Melanoma Res*. [Review / Meta-Analysis]
AI-curated news mentioning malignant melanoma of the mucosa
Updated Jul 23, 2026
A study identifies a somatic HRAS p.Gly12Ser variant as a cause of mosaic RASopathy in a patient with malignant melanoma. This discovery enhances understanding of the genetic underpinnings of RASopathies and their association with cancer.
A systematic review and pooled analysis of primary ovarian malignant melanoma cases has been conducted, providing insights into this rare condition. The findings may help inform future research and treatment strategies for affected patients.